Rob has durable leadership experience in global clinical trial operations, project management and quality for Phase I - IV trials in a variety of therapeutic areas (Oncology, CNS, CV, ID, Diabetes, etc.) for Big Pharma, startup Biotech firms and CROs. He has a consistent record managing cross functional teams & projects - requiring resourcefulness, sustained energy, solid analytical ability, technical understanding and exceptional communications, diplomacy & cultural literacy.
Rob joined AbbVie in 2014 as the Lead for Clinical Planning & Resource Management and later assumed the Director role for Renal & Dyslipidemia in Clinical Program Development. He started his current assignment as Director, Clinical Operations with Japan Development,Tokyo in July 2015.
Prior to joining AbbVie, Rob worked in a variety of capacities in large Pharma (Pfizer, BMS & Lilly), mid-size Biotechs (Targanta, Osiris) and Clinical Research Organizations (Covance, PPD & Translational Medicine India). All roles contributed to his broad understanding of and capabilities within clinical development.
Rob received his undergraduate degree from Gettysburg College in Pennsylvania, USA. He holds a Doctorate in Public Health, MS (Nutritional Biochem & Physiology), & MBA from Columbia University in New York.